These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 32629809)

  • 1. Interaction of Oxidative Stress and Misfolded Proteins in the Mechanism of Neurodegeneration.
    Abramov AY; Potapova EV; Dremin VV; Dunaev AV
    Life (Basel); 2020 Jun; 10(7):. PubMed ID: 32629809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linking Oxidative Stress and Proteinopathy in Alzheimer's Disease.
    Sharma C; Kim SR
    Antioxidants (Basel); 2021 Jul; 10(8):. PubMed ID: 34439479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of misfolded proteins and mitochondria in neurodegenerative disorders.
    Abramov AY; Berezhnov AV; Fedotova EI; Zinchenko VP; Dolgacheva LP
    Biochem Soc Trans; 2017 Aug; 45(4):1025-1033. PubMed ID: 28733489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat shock proteins as suppressors of accumulation of toxic prefibrillar intermediates and misfolded proteins in neurodegenerative diseases.
    Arawaka S; Machiya Y; Kato T
    Curr Pharm Biotechnol; 2010 Feb; 11(2):158-66. PubMed ID: 20170473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
    Hashimoto M; Rockenstein E; Crews L; Masliah E
    Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting oligomers in neurodegenerative disorders: lessons from α-synuclein, tau, and amyloid-β peptide.
    Gadad BS; Britton GB; Rao KS
    J Alzheimers Dis; 2011; 24 Suppl 2():223-32. PubMed ID: 21460436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox regulation of cellular stress response in aging and neurodegenerative disorders: role of vitagenes.
    Calabrese V; Guagliano E; Sapienza M; Panebianco M; Calafato S; Puleo E; Pennisi G; Mancuso C; Butterfield DA; Stella AG
    Neurochem Res; 2007; 32(4-5):757-73. PubMed ID: 17191135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crucial role of protein oligomerization in the pathogenesis of Alzheimer's and Parkinson's diseases.
    Choi ML; Gandhi S
    FEBS J; 2018 Oct; 285(19):3631-3644. PubMed ID: 29924502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox regulation of cellular stress response in neurodegenerative disorders.
    Calabrese V; Guagliano E; Sapienza M; Mancuso C; Butterfield DA; Stella AM
    Ital J Biochem; 2006; 55(3-4):263-82. PubMed ID: 17274531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease.
    Ganguly G; Chakrabarti S; Chatterjee U; Saso L
    Drug Des Devel Ther; 2017; 11():797-810. PubMed ID: 28352155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is alpha-synuclein pathology a target for treatment of neurodegenerative disorders?
    Windisch M; Wolf HJ; Hutter-Paier B; Hofmeister A; Wronski R
    Curr Alzheimer Res; 2007 Sep; 4(4):446-57. PubMed ID: 17908049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review on the cause-effect relationship between oxidative stress and toxic proteins in the pathogenesis of neurodegenerative diseases.
    Borza LR
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(1):19-27. PubMed ID: 24741770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease.
    Jiang T; Sun Q; Chen S
    Prog Neurobiol; 2016 Dec; 147():1-19. PubMed ID: 27769868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phthalocyanines as Molecular Scaffolds to Block Disease-Associated Protein Aggregation.
    Valiente-Gabioud AA; Miotto MC; Chesta ME; Lombardo V; Binolfi A; Fernández CO
    Acc Chem Res; 2016 May; 49(5):801-8. PubMed ID: 27136297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity of extracellular secreted alpha-synuclein: Its role in nitrosative stress and neurodegeneration.
    Wilkaniec A; Strosznajder JB; Adamczyk A
    Neurochem Int; 2013 Apr; 62(5):776-83. PubMed ID: 23416621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases.
    Singh A; Kukreti R; Saso L; Kukreti S
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31013638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
    Maccioni RB; Muñoz JP; Barbeito L
    Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinol (Vitamin A) Increases α-Synuclein, β-Amyloid Peptide, Tau Phosphorylation and RAGE Content in Human SH-SY5Y Neuronal Cell Line.
    Kunzler A; Kolling EA; da Silva JD; Gasparotto J; de Bittencourt Pasquali MA; Moreira JCF; Gelain DP
    Neurochem Res; 2017 Oct; 42(10):2788-2797. PubMed ID: 28497345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Contribution of Iron to Protein Aggregation Disorders in the Central Nervous System.
    Joppe K; Roser AE; Maass F; Lingor P
    Front Neurosci; 2019; 13():15. PubMed ID: 30723395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.